Yuya Sekine

Akita University

Papers

5

Total Citations

21

H-Index

3

About

Yuya Sekine is a leading urological surgeon and researcher whose work centers on optimizing surgical outcomes in robot-assisted radical prostatectomy (RARP) for prostate cancer. His major contributions lie in systematically evaluating factors that influence bleeding, recovery, and oncological control in this minimally invasive procedure. Sekine’s highly cited studies demonstrate that thienopyridine-class antiplatelet agents significantly increase bleeding complications during RARP (7 citations), providing critical guidance for perioperative medication management. He has also shown that advanced age independently elevates complication risks (7 citations), helping surgeons better counsel older patients. Perhaps most notably, Sekine reevaluated the therapeutic role of extended pelvic lymph node dissection in the RARP era (3 citations), challenging conventional wisdom by analyzing real-world outcomes from over 8,000 patients. His work on neurovascular bundle preservation for high-risk prostate cancer (2 citations) and neoadjuvant chemohormonal therapy using GnRH antagonists with low-dose estramustine (2 citations) further expands treatment frontiers. Through these impactful studies, Sekine has established himself as a key voice in refining surgical techniques and perioperative protocols, directly improving patient safety and oncological outcomes in the rapidly evolving field of robotic prostate surgery.

Research Focus

Key Achievements

3
H-Index
5
Papers
21
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Effects of thienopyridine class antiplatelets on bleeding outcomes following robot-assisted radical prostatectomy
7 citations · 2024
📈 Most Prolific Year: 2024 (3 Papers)
🤝 Key Collaborators: 55
🏛 Institutions: Akita University

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago